Design and physicochemical characterization of poly(amidoamine) nanoparticles and the toxicological evaluation in human endothelial cells: applications to peptide delivery to the brain

References

• Balasubramaniam , A . 2002 . Clinical potentials of neuropeptide Y family of hormones . Am J Surg , 183 : 430 – 434 .
   PubMedGoogle Scholar
• Binaschi , A , Bregola , G and Simonato , M . 2003 . On the role of somatostatin in seizure control: clues from the hippocampus . Rev Neurosci , 14 : 285 – 301 .
   PubMedGoogle Scholar
• Strohle , A and Holsboer , F . 2003 . Stress responsive neurohormones in depression and anxiety . Pharmacopsychiatry , 36 : S207 – S214 .
   PubMed Web of Science ®Google Scholar
• Claes , SJ . 2004 . Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology . Ann Med , 36 : 50 – 61 .
   PubMed Web of Science ®Google Scholar
• Datar , P , Srivastava , S , Coutinho , E and Govil , G . 2004 . Substance P: structure, function, and therapeutics . Curr Top Med Chem , 4 : 75 – 103 .
   PubMed Web of Science ®Google Scholar
• Gentilucci , L . 2004 . New trends in the development of opioid peptide analogues as advanced remedies for pain relief . Curr Top Med Chem , 4 : 19 – 38 .
   PubMedGoogle Scholar
• Goldstein , GW and Betz , AL . 1986 . The blood-brain-barrier . Sci Am , 255 : 74 – 83 .
   PubMed Web of Science ®Google Scholar
• Schlosshauer , B . 1993 . The blood-brain-barrier - morphology, molecules, and neurothelin . Bioessays , 15 : 341 – 346 .
   PubMedGoogle Scholar
• Pardridge , WM . 1999 . Blood-brain barrier biology and methodology . J Neurovirol , 5 : 556 – 569 .
   PubMed Web of Science ®Google Scholar
• Abbott , NJ , Ronnback , L and Hansson , E . 2006 . Astrocyte-endothelial interactions at the blood-brain barrier . Nat Rev Neurosci , 7 : 41 – 53 .
   PubMed Web of Science ®Google Scholar
• Lo , EH , Singhal , AB , Torchilin , VP and Abbott , NJ . 2001 . Drug delivery to damaged brain . Brain Res Rev , 38 : 140 – 148 .
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia , E , Andrieux , K , Gil , S and Couvreur , P . 2005 . Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? . Int J Pharm , 298 : 274 – 292 .
   PubMed Web of Science ®Google Scholar
• Smith , QR and Rapoport , SI . 1986 . Cerebrovascular permeability coefficients to sodium, potassium, and chloride . J Neurochem , 46 : 1732 – 1742 .
   PubMed Web of Science ®Google Scholar
• Bodor , N and Buchwald , P . 1999 . Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems . Adv Drug Deliv Rev , 36 : 229 – 254 .
   PubMed Web of Science ®Google Scholar
• Pardridge , WM . 2005 . The blood-brain barrier: bottleneck in brain drug development . NeuroRx , 2 : 3 – 14 .
   PubMedGoogle Scholar
• Levin , VA . 1980 . Relationship of octanol-water partition-coefficient and molecular-weight to rat-brain capillary-permeability . J Med Chem , 23 : 682 – 684 .
   PubMed Web of Science ®Google Scholar
• Pardridge , WM . 2002 . Drug and gene delivery to the brain: the vascular route . Neuron , 36 : 555 – 558 .
   PubMed Web of Science ®Google Scholar
• Kreuter , J . 2001 . Nanoparticulate systems for brain delivery of drugs . Adv Drug Delivery Rev , 47 : 65 – 81 .
   PubMed Web of Science ®Google Scholar
• Ramge , P , Unger , RE , Oltrogge , JB , Zenker , D , Begley , D , Kreuter , J and von Briesen , H . 2000 . Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells . Eur J Neurosci , 12 : 1931 – 1940 .
   PubMed Web of Science ®Google Scholar
• Kreuter , J , Ramge , P , Petrov , V , Hamm , S , Gelperina , SE , Engelhardt , B , Alyautdin , R , von Briesen , H and Begley , DJ . 2003 . Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles . Pharm Res , 20 : 409 – 416 .
   PubMed Web of Science ®Google Scholar
• Kreuter , J . 2004 . Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain . J Nanosci Nanotechnol , 4 : 484 – 488 .
   PubMed Web of Science ®Google Scholar
• Wang , CX , Huang , LS , Hou , LB , Jiang , L , Yan , ZT , Wang , YL and Chen , ZL . 2009 . Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model . Brain Res , 1261 : 91 – 99 .
   PubMed Web of Science ®Google Scholar
• Tahara , K , Miyazaki , Y , Kawashima , Y , Kreuter , J and Yamamoto , H . 2011 . Brain targeting with surface-modified poly(d,l-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration . Eur J Pharm Sci , 77 : 84 – 88 .
   Google Scholar
• Gelperina , S , Maksimenko , O , Khalansky , A , Vanchugova , L , Shipulo , E , Abbasova , K , Berdiev , R , Wohlfart , S , Chepurnova , N and Kreuter , J . 2010 . Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters . Eur J Pharm Sci , 74 : 157 – 163 .
   Google Scholar
• Calvo , P , RemunanLopez , C , VilaJato , JL and Alonso , MJ . 1997 . Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers . J Appl Polym Sci , 63 : 125 – 132 .
   Web of Science ®Google Scholar
• Harada , A and Kataoka , K . 1998 . Novel polyion complex micelles entrapping enzyme molecules in the core: preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium . Macromolecules , 31 : 288 – 294 .
   Web of Science ®Google Scholar
• Jintapattanakit , A , Junyaprasert , VB , Mao , S , Sitterberg , J , Bakowsky , U and Kissel , T . 2007 . Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles . Int J Pharm , 342 : 240 – 249 .
   PubMed Web of Science ®Google Scholar
• Lee , Y , Fukushima , S , Bae , Y , Hiki , S , Ishii , T and Kataoka , K . 2007 . A protein nanocarrier from charge-conversion polymer in response to endosomal pH . J Am Chem Soc , 129 : 5362 – 5363 .
   PubMed Web of Science ®Google Scholar
• Ferruti , P , Marchisio , MA and Barbucci , R . 1985 . Synthesis, physicochemical properties and biomedical applications of poly(amido-amine)s . Polymer , 26 : 1336 – 1348 .
   Web of Science ®Google Scholar
• Ferruti , P , Marchisio , MA and Duncan , R . 2002 . Poly(amido-amine)s: biomedical applications . Macromol Rapid Commun , 23 : 332 – 355 .
   Web of Science ®Google Scholar
• Boussif , O , Lezoualch , F , Zanta , MA , Mergny , MD , Scherman , D , Demeneix , B and Behr , JP . 1995 . A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo - polyethylenimine . Proc Natl Acad Sci USA , 92 : 7297 – 7301 .
   PubMed Web of Science ®Google Scholar
• Wu , CX , Lo , SL , Boulaire , J , Hong , MLW , Beh , HM , Leung , DSY and Wang , S . 2008 . A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro . J Control Release , 130 : 140 – 145 .
   PubMedGoogle Scholar
• Eichman , JD , Bielinska , AU , Kukowska-Latallo , JF and Baker , JR Jr . 2000 . The use of PAMAM dendrimers in the efficient transfer of genetic material into cells . Pharm Sci Technol , 3 : 232 – 245 .
   PubMedGoogle Scholar
• Ranucci , E , Spagnoli , G , Ferruti , P , Sgouras , D and Duncan , R . 1991 . Poly(amidoamine)s with potential as drug carriers: degradation and cellular toxicity . J Biomater Sci Polymer Ed , 2 : 303 – 315 .
   PubMedGoogle Scholar
• Franchini , J , Ranucci , E and Ferruti , P . 2006 . Synthesis, physicochemical properties, and preliminary biological characterizations of a novel amphoteric agmatine-based poly(amidoamine) with RGD-like repeating units . Biomacromolecules , 7 : 1215 – 1222 .
   PubMed Web of Science ®Google Scholar
• Lin , C , Blaauboer , C-J , Timoneda , MM , Lok , MC , van Steenbergen , M , Hennink , WE , Zhong , Z , Feijen , J and Engbersen , JFJ . 2008 . Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery . J Control Release , 126 : 166 – 174 .
   PubMed Web of Science ®Google Scholar
• Lin , C , Zhong , Z , Lok , MC , Jiang , X , Hennink , WE , Feijen , J and Engbersen , JFJ . 2006 . Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties . J Control Release , 116 : 130 – 137 .
   PubMed Web of Science ®Google Scholar
• Lin , C , Zhong , Z , Lok , MC , Jiang , X , Hennink , WE , Feijen , J and Engbersen , JFJ . 2007 . Random and block copolymers of bioreducible poly(amido amine)s with high- and low-basicity amino groups: study of DNA condensation and buffer capacity on gene transfection . J Control Release , 123 : 67 – 75 .
   PubMed Web of Science ®Google Scholar
• Lin , C , Zhong , ZY , Lok , MC , Jiang , XL , Hennink , WE , Feijen , J and Engbersen , JFJ . 2007 . Novel bioreducible poly(amido amine)s for highly efficient gene delivery . Bioconjugate Chem , 18 : 138 – 145 .
   PubMed Web of Science ®Google Scholar
• Mateos-Timoneda , MA , Lok , MC , Hennink , WE , Feijen , J and Engbersen , JFJ . 2008 . Poly(amido amine)s as gene delivery vectors: effects of quaternary nicotinamide moieties in the side chains . ChemMedChem , 3 : 478 – 486 .
   PubMed Web of Science ®Google Scholar
• Coué , G and Engbersen , JFJ . 2011 . Functionalized linear poly(amidoamine)s are efficient vectors for intracellular protein delivery . J Control Release , 152 : 90 – 98 .
   PubMed Web of Science ®Google Scholar
• Cohen , S , Coué , G , Beno , D , Korenstein , R and Engbersen , JFJ . 2012 . Bioreducible poly(amidoamine)s as carriers for intracellular protein delivery to intestinal cells . Biomaterials , 33 : 614 – 623 .
   PubMedGoogle Scholar
• Meng , FH , Hennink , WE and Zhong , Z . 2009 . Reduction-sensitive polymers and bioconjugates for biomedical applications . Biomaterials , 30 : 2180 – 2198 .
   PubMed Web of Science ®Google Scholar
• Rajender , KC , Frederick , WL , Michael , HK , David , MB , Robert , GBR and Daniel , R . 1984 . Plasma cysteine, cystine, and glutathione in cirrhosis . Gastroenterology , 87 : 770 – 776 .
   PubMedGoogle Scholar
• Bernkop-Schnürch , A . 2005 . Thiomers: a new generation of mucoadhesive polymers . Adv Drug Delivery Rev , 57 : 1569 – 1582 .
   PubMed Web of Science ®Google Scholar
• Lin , C and Engbersen , JFJ . 2009 . The role of the disulfide group in disulfide-based polymeric gene carriers . Expert Opin Drug Deliv , 6 : 421 – 439 .
   PubMed Web of Science ®Google Scholar
• Emilitri , E , Ranucci , E and Ferruti , P . 2005 . New poly(amidoamine)s containing disulfide linkages in their main chain . J Polym Sci Pol Chem , 43 : 1404 – 1416 .
   Web of Science ®Google Scholar
• Emilitri , E , Ferruti , P , Annunziata , R , Ranucci , E , Rossi , M , Falciola , L , Mussini , P , Chiellini , F and Bartoli , C . 2007 . Novel amphoteric cystine-based poly(amidoamine)s responsive to redox stimuli . Macromolecules , 40 : 4785 – 4793 .
   Web of Science ®Google Scholar
• Matsuoka , Y , Jouroukhin , Y , Gray , AJ , Ma , L , Hirata-Fukae , C , Li , HF , Feng , L , Lecanu , L , Walker , BR , Planel , E , Arancio , O , Gozes , I and Aisen , PS . 2008 . A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer’s disease . J Pharmacol Exp Ther , 325 : 146 – 153 .
   PubMed Web of Science ®Google Scholar
• Leker , RR , Teichner , A , Grigoriadis , N , Ovadia , H , Brenneman , DE , Fridkin , M , Giladi , E , Romano , J and Gozes , I . 2002 . NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death . Stroke , 33 : 1085 – 1092 .
   PubMed Web of Science ®Google Scholar
• Gozes , I , Morimoto , BH , Tiong , J , Fox , A , Sutherland , K , Dangoor , D , Holser-Cochav , M , Vered , K , Newton , P , Aisen , PS , Matsuoka , Y , van Dyck , CH and Thal , L . 2005 . NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP) . CNS Drug Rev , 11 : 353 – 368 .
   PubMedGoogle Scholar
• Gozes , I , Divinsky , I , Pilzer , I , Fridkin , M , Brenneman , DE and Spier , AD . 2003 . From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP - a view of neuroprotection and cell division . J Mol Neurosci , 20 : 315 – 322 .
   PubMed Web of Science ®Google Scholar
• Weksler , BB , Subileau , EA , Perrière , N , Charneau , P , Holloway , K , Leveque , M , Tricoire-Leignel , H , Nicotra , A , Bourdoulous , S and Turowski , P . 2005 . Blood–brain barrier-specific properties of a human adult brain endothelial cell line . FASEB (Fed Am Soc Exp Biol) J , 19 : 1872 – 1874 .
   PubMed Web of Science ®Google Scholar
• Jaffe , EA , Nachman , RL , Becker , CG and Minick , CR . 1973 . Culture of human endothelial cells derived from umbilical veins . J Clin Invest , 52 : 2745 – 2756 .
   PubMed Web of Science ®Google Scholar
• Unger , RE , Krump-Konvalinkova , V , Peters , K and Kirkpatrick , CJ . 2002 . In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line, HPMEC-ST1.6R . Microvasc Res. , 64 : 384 – 397 .
   PubMedGoogle Scholar